Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
First Oral Therapy
.
Show all posts
Showing posts with label
First Oral Therapy
.
Show all posts
Thursday, April 2, 2026
FDA Accepts Shionogi’s Ensitrelvir NDA for Review as the First Oral Therapy for the Prevention of COVID-19 Following Exposure
›
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the U.S...
›
Home
View web version
